Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: Report from the children's oncology group

Journal of Clinical Oncology

Volumn 32, Issue 5, 2014, Pages 465-470

  Billmire, Deborah F ^a   Cullen, John W ^b   Rescorla, Frederick J ^a   Davis, Mary ^c   Schlatter, Marc G ^c   Olson, Thomas A ^d   Malogolowkin, Marcio H ^e   Pashankar, Farzana ^f   Villaluna, Doojduen ^g   Krailo, Mark ^h   Egler, Rachel A ⁱ   Rodriguez Galindo, Carlos ^j   Frazier, A Lindsay ^j  

^a INDIANA UNIVERSITY   (United States)

^b PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^c HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^d EMORY UNIVERSITY   (United States)

^e Children's Hospital of Wisconsin   (United States)

^f YALE UNIVERSITY   (United States)

^g Children's Oncology Group   (Liberia)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFP PROTEIN, HUMAN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADOLESCENT; ARTICLE; BLOOD; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INFANT; KAPLAN MEIER METHOD; METABOLISM; METASTASIS; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTICENTER STUDY; NEOPLASM; NEWBORN; OVARY TUMOR; PATHOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; RISK FACTOR; SALVAGE THERAPY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RISK FACTORS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897577103     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.1006     Document Type: Article

References (20)

1. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404-2419, 1976 (Pubitemid 8015876)
2. Einhorn LH, Donohue JP: Improved chemotherapy in disseminated testicular cancer. J Urol 117:65-69, 1977 (Pubitemid 8022657)
3. Cushing B, Giller R, Cullen JW, et al: Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: A pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 22:2691-2700, 2004 (Pubitemid 41103757)
4. Rogers PC, Olson TA, Cullen JW, et al: Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study - Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22:3563-3569, 2004 (Pubitemid 41103663)
5. Hale GA, Marina NM, Jones-Wallace D, et al: Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115-122, 1999 (Pubitemid 30303874)
6. Travis LB, Beard C, Allan JM, et al: Testicular cancer survivorship: Research strategies and recommendations. J Natl Cancer Inst 102:1114-1130, 2010
7. Kollmannsberger C, Moore C, Chi KN, et al: Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: Diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 21:1296-1301, 2010
8. Schlatter M, Rescorla F, Giller R, et al: Excellent outcome in patients with stage I germ cell tumors of the testes: A study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg 38:319-324, 2003; discussion 319-324
9. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 2002
10. Woolson RF: Rank tests and a one-sample logrank test for comparing observed survival data to a standard population. Biometrics 37:687-696, 1981
11. Demets DL: Group sequential procedures: Calendar versus information time. Stat Med 8:1191-1198, 1989
12. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers - International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594-603, 1997
13. Palenzuela G, Martin E, Meunier A, et al: Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary. Ann Surg 248:836-841, 2008
14. Baranzelli MC, Bouffet E, Quintana E, et al: Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36:376-383, 2000 (Pubitemid 30116735)
15. Mann JR, Raafat F, Robinson K, et al: The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
16. Calaminus G, Göbel U, Teske C, et al: Prognosis and outcome of ovarian germ cell tumors-final results of the German MAKEI 96 trial. Presented at the 42nd Congress of the International Society of Paediatric Oncology, Boston, MA, October 21-24, 2010
17. Patterson DM, Murugaesu N, Holden L, et al: A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer 18:43-50, 2008
18. Dark GG, Bower M, Newlands ES, et al: Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620-624, 1997 (Pubitemid 27074230)
19. Mitchell PL, Al-Nasiri N, A'Hern R, et al: Treatment of nondysgerminomatous ovarian germ cell tumors: An analysis of 69 cases. Cancer 85:2232-2244, 1999 (Pubitemid 29215564)
20. Billmire D, Vinocur C, Rescorla F, et al: Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: An intergroup study. J Pediatr Surg 39:424-429, 2004; discussion 424-429